Testicular Cancer: Young Age, Chemo Failure, Spreads Post-Testicular Surgery, Worse Recurrences, Poor Prognosis

Features of COVID-19 mRNA Vaccine Testicular Turbo Cancer; 40 Cases

By Dr. William Makis
Global Research, October 19, 2023
COVID Intel
Theme:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

***

July 24, 2023 – Walnut Creek, CA – 37 year old Iraq War Veteran Joseph Kim fought a 54 day battle with testicular cancer, and died on July 24, 2023.

Oct. 18, 2023 – Gunnison, CO – 26 year old Dylan Miller was diagnosed with Stage 1 testicular cancer in April 2023, but by Oct.2023 it returned and he has 4 different types of cancer in the recurrent tumor (!)

Oct. 17, 2023 – Famington, MI – Ben Cousens was diagnosed with Stage 4 testicular cancer in March 2023 with “innumerable amount of nodules on his lungs” and a “very large mass in his lower back and mass on his testicle”. He has had surgery and chemo and is waiting for next step in treatment.

Oct. 15, 2023 – Cincinnati, OH – 21 year old Ben Schlaack was diagnosed with aggressive testicular cancer and had surgery. After surgery they discovered it had spread to lymph nodes.

Oct. 9, 2023 – Winter Springs, FL – 22 year old Chase Dowling had a benign testicular tumor removed in April 2023. It returned in Oct.2023 and is now metastatic in his lymph nodes. Benign to metastatic in 5 months!

Oct. 6, 2023 – Grottoes, VA – Chris Roberts had extensive surgery for testicular cancer in Dec. 2022 and was clear of cancer in April 2023. However, in May 2023, he was found to have bone marrow metastases and the cancer came back a different, more aggressive type: embryonic neuroectodermal, with a terminal diagnosis.

Oct. 2, 2023 – Melbourne, Australia – Scott was diagnosed with two different types of cancer in both testicles in May 2023. He had them removed, however after surgery, imaging showed cancer spread to his lymph nodes.

Sep. 25, 2023 – San Antonio, TX – 18 year old Nehemiah Alvarado, a gifted carpenter, was diagnosed with Stage 4 Testicular Cancer with lung metastases. He had chemo and surgery, however, his cancer continues to progress.

Sep. 24, 2023 – Barrie, ON – 29 year old Saifali Mansabdar was diagnosed with blood clots around the heart and lungs on Feb. 15, 2023 and testicular cancer. He then suffered 2 cardiac arrests on Sep. 11, 2023, putting him in coma, and he died on Sep. 24, 2023.

Sep. 10, 2023 – UK – 33 year old Paddy Dowling was diagnosed with testicular cancer in January 2023 and was told he had 90% chance of beating it. His cancer resisted chemo and radiation, he developed brain metastases and died 8 months after diagnosis.

Sep. 1, 2023 – Falfurrias, TX – 18 year old Kaidyn Longoria was diagnosed with Stage 4 testicular cancer in March 2023, metastatic to right lung. After 1st round of chemo he had a cardiac arrest, brain bleed, and was found to have two brain lesions. But he finished 4 rounds of chemo and is currently in remission.

Aug. 28, 2023 – Westland, MI – Mike Trader has two small girls. He was diagnosed with Testicular cancer but it has spread to retroperitoneal lymph nodes and there is another cancerous growth.

Aug. 14, 2023 – San Antonio, TX – 23 year old Irvin Alan Tapia was diagnosed with testicular cancer on June 25, 2023 and died 50 days later on Aug. 14, 2023.

Aug. 11, 2023 – Colona, IL – 21 year old Kaden was diagnosed with 2 types of testicular cancer on July 7, 2023. After surgery, his PET scan on Aug. 7, 2023 showed that the State 2 cancer had metastasized to 3 of his lymph nodes.

Aug. 9, 2023 – The Dalles, OR – Cody Ricks was diagnosed with testicular cancer Sep. 2022 and after chemo and surgery he was clear of cancer. However, it returned on May 22, 2023 and had to have a stem cell transplant.

July 12, 2023 – Bremen, IN – Craig Allen was diagnosed with Stage 3c Testicular cancer in Jan. 2023, however, it was resistant to a chemo protocol that’s 85% successful and progressed. Now he needs more aggressive chemo.

July 10, 2023 – Charlton, QLD, Australia – 24 year old Benny was diagnosed with Testicular cancer in March 2023. Had surgery and chemo but on July 4, 2023 he was told the chemo didn’t work and cancer spread to his brain liver, and kidneys, then the spleen.

July 7, 2023 – Manassas, VA 24 year old Christian A. Merse had late stage germ cell testicular cancer that invaded his organs within weeks. It was treatment resistant & he died.

July 7, 2023 – Overland Park, KS 23 year old Peyton Rowe was diagnosed: Stage 3C Testicular cancer spread to his lymph nodes, spine & lungs. “Tumor was very aggressive.”

June 14, 2023 – Metairie, LA – 20 year old Bryan Ibanez is a NURSING student at Missouri State U. In Sep. 2022 he was diagnosed with Stage 2 testicular cancer which turned to Stage 4 with lung metastases by May 2023. Bryan spent his high school years working at a local nursing home as a dedicated CNA.

Read all cases here.

My Take… 

There is a very strong signal with Pfizer and Moderna COVID-19 mRNA Vaccines and hyper aggressive Testicular “Turbo Cancer”.

  • Unique Features of mRNA Induced Testicular Turbo Cancer include:
  • Young age at presentation (teens, 20s, 30s)
  • Stage 4 presentation, or a lower stage that rapidly progresses
  • can have multiple tumor types
  • surgeons discover further spread after surgery (orchiectomy)
  • very resistant to chemo and radiation
  • very aggressive metastatic spread to organs and bones
  • testicular cancer recurrences often transform into more aggressive type
  • very poor prognosis

Recent news on cancer excess deaths in 2022:

Edward Dowd has released new data on Cancer excess deaths in England and Wales and the data looks horrible.

Turbo Cancer skyrocketed in 2022 and I believe there has been a further worsening in 2023:

Sep. 2022 News – BioNTech CLAIMS TO CURE ONE TESTICULAR CANCER PATIENT

“BNT211’s therapeutic approach combines two of BioNTech’s platforms—an autologous CAR-T cell therapy targeting the oncofetal antigen Claudin-6 (CLDN6) with a CLDN6-encoding CAR-T cell amplifying RNA vaccine (CARVac).

“Particularly encouraging, according to BioNTech, were the clinical responses were seen in patients with testicular cancer treated with the larger dose:  One complete response, three partial responses and two stable diseases were seen”

“Antitumor activity was higher at the higher dose of CAR-T cells and when combined with the mRNA vaccine.”

“In June (2022), BNT211 received the European Medicines Agency (EMA)’s Priority Medicines (PRIME) designation for the third- or later-line treatment of testicular germ cell tumors.”

“This new dataset further supports the encouraging results we have seen for BNT211 to date,” said Prof. Özlem Türeci, MD, Co-Founder and chief medical officer at BioNTech. “Together with the recently granted PRIME designation for BNT211 in testicular cancer it also reinforces our strategy to combine two of our key technology platforms in hard-to-treat tumor indications.”

“Tumor indications included testicular cancer (13 patients), ovarian cancer (four), endometrial cancer, fallopian tube cancer, sarcoma, gastric cancer (one patient each) and one patient with a tumor of unknown primary origin”

What is CAR-T cell Therapy: “Currently available CAR-T cell therapies are customized for each individual patient. They are made by collecting T cells from the patient and re-engineering them in the laboratory to produce proteins on their surface called chimeric antigen receptors, or CARs. The CARs recognize and bind to specific proteins, or antigens, on the surface of cancer cells. 

After the revamped T-cells are “expanded” into the millions in the laboratory, they’re then infused back into the patient. If all goes as planned, the CAR-T cells will continue to multiply in the patient’s body and, with guidance from their engineered receptor, recognize and kill any cancer cells that harbor the target antigen on their surfaces.

Conclusion

Pfizer’s partner, BioNTech already has a combination testicular cancer treatment in Clinical Trials (called BNT211) that combines CAR-T cell therapy (something that works) with an mRNA cancer vaccine (something that doesn’t work).

Notice that this therapy is designed for reproductive cancers for both men and women.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Dr. William Makis is a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar. Author of 100+ peer-reviewed medical publications.

Featured image is from COVID Intel

The Worldwide Corona Crisis, Global Coup d’Etat Against Humanity

by Michel Chossudovsky

Michel Chossudovsky reviews in detail how this insidious project “destroys people’s lives”. He provides a comprehensive analysis of everything you need to know about the “pandemic” — from the medical dimensions to the economic and social repercussions, political underpinnings, and mental and psychological impacts.

“My objective as an author is to inform people worldwide and refute the official narrative which has been used as a justification to destabilize the economic and social fabric of entire countries, followed by the imposition of the “deadly” COVID-19 “vaccine”. This crisis affects humanity in its entirety: almost 8 billion people. We stand in solidarity with our fellow human beings and our children worldwide. Truth is a powerful instrument.”

Reviews

This is an in-depth resource of great interest if it is the wider perspective you are motivated to understand a little better, the author is very knowledgeable about geopolitics and this comes out in the way Covid is contextualized. —Dr. Mike Yeadon

In this war against humanity in which we find ourselves, in this singular, irregular and massive assault against liberty and the goodness of people, Chossudovsky’s book is a rock upon which to sustain our fight. –Dr. Emanuel Garcia

In fifteen concise science-based chapters, Michel traces the false covid pandemic, explaining how a PCR test, producing up to 97% proven false positives, combined with a relentless 24/7 fear campaign, was able to create a worldwide panic-laden “plandemic”; that this plandemic would never have been possible without the infamous DNA-modifying Polymerase Chain Reaction test – which to this day is being pushed on a majority of innocent people who have no clue. His conclusions are evidenced by renown scientists. —Peter Koenig 

Professor Chossudovsky exposes the truth that “there is no causal relationship between the virus and economic variables.” In other words, it was not COVID-19 but, rather, the deliberate implementation of the illogical, scientifically baseless lockdowns that caused the shutdown of the global economy. –David Skripac

A reading of  Chossudovsky’s book provides a comprehensive lesson in how there is a global coup d’état under way called “The Great Reset” that if not resisted and defeated by freedom loving people everywhere will result in a dystopian future not yet imagined. Pass on this free gift from Professor Chossudovsky before it’s too late.  You will not find so much valuable information and analysis in one place. –Edward Curtin

ISBN: 978-0-9879389-3-0,  Year: 2022,  PDF Ebook,  Pages: 164, 15 Chapters

Price: $11.50 FREE COPY! Click here (docsend) and download.

We encourage you to support the eBook project by making a donation through Global Research’s DonorBox “Worldwide Corona Crisis” Campaign Page. 
Articles by: Dr. William Makis

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]